Concepedia

Todd Grinnell

TG

Statistics

Publications

14

Citations

379

H-Index

11

Active since

2012

Affiliations

Vion Pharmaceuticals (United States)(Current)

Sunovion (United States)

Sunovion (United Kingdom)

Bial (Portugal)

Thomas Jefferson University

Todd Grinnell is an author at Vion Pharmaceuticals (United States) specializing in pharmacotherapy, pharmacology, and clinical pharmacology.

Publications per year

2012–2023

14

Publications

14

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial‐onset seizures: A randomized historical‐control phase <scp>III</scp> study based in North America

Michael R. Sperling, Jay Harvey, Todd Grinnell et al. · Epilepsia · 2015 · 76 citations · Full text

, , +16

Efficacy and safety of conversion to monotherapy with eslicarbazepine acetate in adults with uncontrolled partial-onset seizures: a historical-control phase III study

Mercedes Jacobson, Ladislav Pazdera, Perminder Bhatia et al. · BMC Neurology · 2015 · 53 citations · Full text

, , +17

Adjunctive eslicarbazepine acetate: A pooled analysis of three phase III trials

Victor Biton, Joanne Rogin, Gregory L. Krauss et al. · Epilepsy & Behavior · 2017 · 48 citations · Full text

, , +15

Eszopiclone for Insomnia Associated With Attention-Deficit/Hyperactivity Disorder

R. Bart Sangal, Jeffrey L. Blumer, D. Alan Lankford et al. · PEDIATRICS · 2014 · 39 citations

, , +17

Conversion to eslicarbazepine acetate monotherapy

Michael R. Sperling, Jacqueline A. French, Mercedes Jacobson et al. · Neurology · 2016 · 36 citations · Full text

, , +15

1–5 of 14